Apr 13, 2026 08:30AM
Aug 14, 2025 04:05PM
Jul 7, 2025 08:32AM
Jul 7, 2025 08:30AM
May 15, 2025 04:05PM
Mar 31, 2025 04:05PM
Mar 5, 2025 04:17PM Mustang Bio (MBIO) Regains Nasdaq Compliance
Mar 5, 2025 04:15PM
Feb 27, 2025 04:06PM
Feb 27, 2025 04:05PM
Feb 11, 2025 04:11PM
Feb 11, 2025 04:10PM
Feb 10, 2025 08:00AM
Feb 6, 2025 07:01AM Mustang Bio (MBIO) Prices 2.66M Share Offering at $3.01/sh
Feb 6, 2025 07:00AM
Jan 14, 2025 08:02AM
Jan 14, 2025 08:00AM
Nov 14, 2024 04:10PM
Nov 12, 2024 08:31AM
Nov 12, 2024 08:30AM
Nov 7, 2024 08:32AM Mustang Bio (MBIO) Granted FDA Orphan Drug Designation for MB-108
Nov 7, 2024 08:30AM
Oct 24, 2024 02:10PM
Oct 24, 2024 02:10PM
Aug 13, 2024 04:05PM
Jun 21, 2024 04:01PM
Jun 20, 2024 08:01AM
Jun 20, 2024 08:00AM Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Jun 17, 2024 08:31AM
Jun 17, 2024 08:30AM
May 15, 2024 04:15PM
May 2, 2024 04:01PM
Apr 29, 2024 08:00PM
Mar 28, 2024 04:05PM
Mar 28, 2024 09:03AM Mustang Bio (MBIO) Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases
Mar 28, 2024 09:00AM
Mar 11, 2024 04:05PM
Mar 7, 2024 07:31AM
Mar 7, 2024 07:30AM
Jan 11, 2024 08:30AM
Dec 11, 2023 08:31AM
Dec 11, 2023 08:30AM Mustang Bio Presents Updated Phase 1/2 Multicenter Clinical Data for MB-106 at the 2023 American Society of Hematology (ASH) Annual Meeting
Nov 14, 2023 04:10PM
Nov 14, 2023 04:05PM
Nov 2, 2023 09:28AM
Oct 30, 2023 02:15PM
Oct 26, 2023 12:31PM
Oct 26, 2023 12:30PM
Oct 26, 2023 09:03AM Mustang Bio (MBIO) Announces FDA Acceptance of IND Application for MB-109, a Novel Combination of MB-101 and MB-108, for Treatment of Recurrent Glioblastoma and High-Grade Astrocytoma
Oct 26, 2023 09:00AM

1,156,796 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All